Feasibility and efficacy of external beam radiotherapy after hyperthermic isolated limb perfusion with TNF-α and melphalan for limb- saving treatment in locally advanced extremity soft-tissue sarcoma

International Journal of Radiation Oncology Biology Physics

Volumn 40, Issue 4, 1998, Pages 807-814

  Olieman, Annette F T ^a   Pras, Elisabeth ^a   Van Ginkel, Robert J ^a   Molenaar, Willemina M ^a   Koops, Heimen Schraffordt ^a   Hoekstra, Harald J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Limb perfusion; Radiotherapy; Sarcoma; Tumor necrosis factor

Indexed keywords

MELPHALAN; RECOMBINANT GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HYPERTHERMIC THERAPY; LIMB SALVAGE; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; REGIONAL PERFUSION; SOFT TISSUE SARCOMA; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMPUTATION; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; EXTREMITIES; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; INTERFERON TYPE II; MALE; MELPHALAN; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; SARCOMA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031945945     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00923-1     Document Type: Article

References (47)

1. Wingo P. A., Tong T., Bolder S. Cancer statistics. CA Cancer J. Clin. 45:1995;8-30.
2. Hoekstra H. J., Schraffordt Koops H., Oldhoff J. Soft tissue sarcoma of the extremity. Eur. J. Surg. Oncol. 20:1994;3-6.
3. Chang A. E., Sondak V. K. Clinical evaluation and treatment of soft tissue tumors. Enzinger F. M., Weiss S. W. Soft tissue tumours. 3rd ed. 1995;17-31 C.V. Mosby, St Louis.
4. Mazanet R., Antman K. H. Sarcomas of soft tissue and bone. Cancer. 68:1991;463-473.
5. Sadoski C., Suit H. D., Rosenberg A., Mankin H., Efird J. Preoperative radiation, surgical margins and local control of extremity sarcomas of soft tissues. J. Surg. Oncol. 52:1993;223-230.
6. Simon M. A., Spainer S. S., Enneking W. F. Management of adult soft tissue sarcomas of the extremities. J. Bone Joint Surg. Am. 58:1976;317-327.
7. Rosenberg S. A., Tepper F., Glatstein E., Costa J., Baker A., Brennan M., et al. The treatment of soft tissue sarcomas of the extremities Prospective randomized evaluations of (1) limb sparing surgery plus radiation compared to amputation, and (2) the role of adjuvant chemotherapy . Ann. Surg. 96:1982;305-315.
8. Brennan M. F., Hilaris B., Shiu M. H. Local recurrence in adult soft tissue sarcoma A randomized trial of brachytherapy . Arch. Surg. 122:1987;1289-1293.
9. Suit, H. D.; Mankin, H. J.; Wood, W. C.; et al. Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcomas. Cancer 2659-2667; 1985.
10. Eilber F., Eckhardt J., Rosen G., Forscher C., Selch M. Improved complete response rate with neoadjuvant chemotherapy and radiation for high grade extremity soft tissue sarcoma. Proc. Am. Soc. Clin. Oncol. 13:1994;473.
11. Rydholm A., Gustafson P., Rooser B., et al. Limb-sparing without radiotherapy based on anatomic location of soft tissue sarcoma. J Clin. Oncol. 9:1991;1757-1765.
12. Creech O. J., Krementz E. T., Ryan R. F., Windblad J. N. Chemotherapy of cancer Regional perfusion utilizing an extracorporal circuit . Ann. Surg. 148:1958;616-632.
13. Baas P. C., Schraffordt Koops H., Hoekstra H. J., Oosterhuis J. W., Weele L. T., van der Oldhoff J. Isolated regional perfusion in the treatment of local recurrence, satellitosis and intransit metastasis of the extremities. Reg. Cancer Treat. 1:1988;33-36.
14. Filipo F. D., Calabro A. M., Cavallari A., et al. The role of hyperthermic perfusion as a first step in the treatment of soft tissue sarcomas of the extremities. W. J. Surg. 12:1988;332-339.
15. van Ginkel R. J., Schraffordt Koops H., de Vries E. G. E., et al. Hyperthermic isolated limb perfusion with cisplatin for sarcomas of soft tissue and bone. Eur. J. Surg. 22:1996;528-531.
16. Hoekstra H. J., Schraffordt Koops H., Molenaar W. M., Oldhoff J. Results of isolated regional perfusion in the treatment of malignant soft tissue tumours of the extremities. Cancer. 60:1987;1703-1707.
17. Klaase J. M., Kroon B. B. R., Benckhuysen C., Van Geel A. N., Albus-Lutter C. E., Wieberdink J. Results of regional isolation perfusion with cytostatics in patients with soft tissue tumors of the extremities. Cancer. 64:1989;616-621.
18. Krementz E. T., Carter R. D., Sutherland C. M., Hutton I. Chemotherapy of sarcomas of the limbs by regional perfusion. Ann. Surg. 185:1977;555-564.
19. Lehti P. M., Mosely H. S., Janoff K., Stevens K., Fletcher W. S. Improved survival for soft tissue sarcoma of the extremities by regional hyperthermic perfusion, local excision and radiation therapy. Surg. Gynecol. Obstet. 162:1986;149-152.
20. Rossi C. R., Vecchiato A., Foletto M., et al. Phase II study on neoadjuvant hyperthermic antiblastic perfusion with doxorubicin in patients with intermediate high grade limb sarcomas. Cancer. 73:1994;2140-2146.
21. Guchelaar H. J., Hoekstra H. J., Uges D. R. A., Oosterhuis J. W., Schraffordt Koops H., de Vries W. G. E. Pharmacokinetics of cisplatin and platinum in hyperthermic isolated regional perfusion in the treatment of human tumours of the extremities. Br. J. Cancer. 65:1992;898-902.
22. Thompson J. F., Giatoutsos M. P. Isolated perfusion for melanoma Effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs . W. J. Surg. 61:1992;227-233.
23. Lienard D., Delmotte J. J., Renard N., Ewalenko P., Lejeune F. J. High-dose recombinant tumour necrosis factor-alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J. Clin. Oncol. 10:1992;52-60.
24. Eggermont A. M. M., Schraffordt Koops H., Lienard D., et al. High dose TNF-alpha in combination with gamma interferon and melphalan in isolated perfusion of the limb for irresectable soft tissue sarcomas A highly effective approach to achieve limb salvage . J. Clin. Oncol. 14:1996;2653-2665.
25. Hogeboom W. R., Hoekstra H. J., Mooyaart E. L., Freling N. J. M., Schraffordt Koops H. MRI or CT in the preoperative evaluation of soft tissue tumors. Arch. Orthop. Trauma Surg. 110:1991;162-164.
26. Olieman A. F. T., van Ginkel R. J., Hoekstra H. J., Mooyaart E. L., et al. The angiographic response of locally advanced soft tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor. Ann. Surg. Oncol. 4:1997;64-69.
27. Nieweg, O. E.; Pruim, J.; van Ginkel, R. J.; et al. Fluorine-18-fluorode oxygenase PET imaging of soft tissue sarcomas. J. Nucl. Med. 37:257-226; 1996.
28. Molenaar W. M., van den Berg E., Dolfin A. C., Zorgdrager H., Hoekstra H. J. Cytogenetics of fine needle aspiration biopsies of sarcomas. Cancer Genet. Cytogenet. 84:1995;27-31.
29. Trojani M., Contesso G., Coindre J. M., et al. Soft-tissue sarcomas of adults Study of pathologic prognostic variables and definition of a histopathological grading system . Int. J. Cancer. 33:1984;37-42.
30. Beatres O. H., Henson D. E., Huttec R. V., Meyers M. H. Manual for staging of cancer. 1988;127-133 J. B. Lippincott, Philadelphia.
31. Fontyne W. P., Mook P. H., Schraffordt Koops H., et al. Improved tissue perfusion during pressure regulated regional perfusion A clinical study . Cancer. 55:1985;1455-1461.
32. Schraffordt Koops H., Oldhoff J., Oosterhuis J. W., Beekhuis J. Isolated regional perfusion in malignant melanoma of the extremities. W. J. Surg. 11:1987;527-533.
33. Hoekstra H. J., Naujocks T., Schraffordt Koops H., et al. Continuous leakage monitoring during hyperthermic isolated regional perfusion of the lower limb technique and results . Reg. Cancer Treat. 4:1992;301-304.
34. Pavy J. J., Denekamp J., Letschert B., Littbrand F., Mornex J., et al. Late effects toxicity scoring The SOMA scale . Radiother. Oncol. 35:1995;11-15.
35. Carswell, E. A.; Old, L. J.; Kassel, R. L.; Green, S.; Fiore, N.; Williamson, B. An endotoxin induced serum factor that causes necrosis of tumours. Proc. Nat. Acad. Sci. USA 72:3666-3370; 1975.
36. Feinberg B., Kurzrock R., Talpaz M., Blick M., Saks S., Gutterman J. U. A phase-1 trial of intravenously administered recombinant tumor necrosis factor alpha in cancer patients. J. Clin. Oncol. 6:1988;1328-1334.
37. Le J., Vilcek J. Tumour necrosis factor and interleukin 1 Cytokines with multiple overlapping biological activities . Lab. Invest. 56:1987;234-248.
38. Pan M., Wasa M., Lind S., Gertler J., Abbott W., Suoba W. TNF-α stimulated arginine transport by human endothelium requires activation of protein kinase. C. Ann. Surg. 221:1995;590-601.
39. Renard N., Lienard D., Lespagnard L., Eggermont A., Heirnan R., Lejeune F. Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumour necrosis factor alpha (rTNFα). Int. J. Cancer. 57:1994;656-663.
40. van Ginkel R. J., Hoekstra H. J., Pruim J., et al. FDG PET to evaluate the response to hyperthermic isolated limb perfusion for locally advanced soft tissue sarcoma. J. Nucl. Med. 37:1996;984-990.
41. Hoekstra H. J., van Ginkel R. J., Pras E., Molenaar W. M., Schraffordt Kopps H. The feasibility of adjuvant external beam radiotherapy (EBRT) after limb saving treatment of locally advanced soft tissue sarcoma (STS) of the extremity with hyperthermic isolated limb perfusion (HILP) with TNF and melphalan. J. Clin. Oncol. 15:1996;1677.
42. Olieman, A. F. T.; van Ginkel, R. J.; Molenaar, W. M.; Schraffordt Koops, H.; Hoekstra, H. J. Hyperthermic isolated limb perfusion with TNF-α and melphalan as palliative limb saving treatment in patients with locally advanced soft tissue sarcomas of the extremities with regional or distant metastases. Is it worthwhile? Br. J. Surg. Submitted.
43. van Ginkel R. J., Hoekstra H. J., Eggermont A. M. M., et al. Isolated limb perfusion with TNF, interferon and melphalan of an irradiated foot A dramatic local effect . Arch. Surg. 131:1996;672-674.
44. Reece G. P., Schusserman M. A., Pollock R. E., et al. Immediate versus delayed free-tissue transfer salvage of the lower extremity in soft tissue sarcoma patients. Ann. Surg. Oncol. 1:1994;11-18.
45. Hoekstra H. J., Schraffordt Koops H., Molenaar W. M., Mehta D. M., Sleijfer D. T., Dijkhuis G., Oldhoff J. A combination of intraarterial chemotherapy, preoperative and postoperative radiotherapy, and surgery as limb saving treatment of primarily unresectable high-grade soft tissue sarcomas of the extremities. Cancer. 63:1989;59-62.
46. Nijhuis P., Pras E., Sleijfer D. T., Molenaar W. M., Schraffordt Koops H., Hoekstra H. J. Morbidity of a combined modality therapy of i.a. doxorubicin, neoadjuvant radiotherapy and surgery for locally advanced high grade soft tissue sarcomas (STS) of the extremities. Int. J. Radiat. Oncol. Biol. Phys. 39:(suppl. 2):1997;158.
47. Eggermont A. M. M., Schraffordt Koops H., Klausner J., Kroon B. B. R., Schlag P. M., et al. Isolated limb perfusion with tumour necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas The cumulative multicenter European experience . Ann. Surg. 224:1996;756-765.